Maximize your upstream viral vector scale-up: Strategies for adherent and suspension cells

Whatever your scale, Cytiva is here to support you with single-use bioreactors for adherent and suspension cells from seed train to manufacturing.

In this webinar, we will explore the diverse options available for both adherent and suspension cell cultures, emphasizing key factors to consider when making your initial selection. Additionally, we will showcase the scalability of our bioreactors, demonstrating how they can seamlessly support your process from lab to production scale.

What You Will Learn:

• Critical factors in choosing between adherent and suspension cells at the outset of your process.
• A detailed presentation of bioreactors designed for both cell culture methods.
• Insights into Cytiva’s proven track record, featuring compelling case studies that highlight our success in the field.

Speakers:

Megan Cloughley

Sr. Upstream Genomic Medicine Field Applications Specialist

Megan Cloughley:

Megan joined Cytiva in 2021 as a bioreactor applications specialist, leveraging her background in upstream process development to make significant contributions, and in 2023 became part of the Genomic Medicine Operating Company, which primarily focuses on viral vectors. Prior to Cytiva, Megan worked in upstream process development at a CMO and in a robustness laboratory at a major pharmaceutical company. She holds a Master's degree in Bioengineering with a concentration in Tissue Engineering from Trinity College Dublin. Outside of her professional work in biologics, Megan is an avid traveler, marathon runner, and foodie.